Social News XYZ     

FDA approves drug to treat postpartum depression (Video)

         The U.S. Food and Drug Administration has approved the first drug specifically developed to treat postpartum depression. The agency on Tuesday approved Sage Therapeutics' Zulresso, a physician administered IV drug given over 2 ½ days. (March 20)

Subscribe for more Breaking News: http://smarturl.it/AssociatedPress
Website: https://apnews.com
Twitter: https://twitter.com/AP
Facebook: https://facebook.com/APNews
Google+: https://plus.google.com/115892241801867723374
Instagram: https://www.instagram.com/APNews/

You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/84d2a6abe6681a534e12d41b878068f7

Facebook Comments
FDA approves drug to treat postpartum depression  (Video)

About Gopi

Gopi Adusumilli is a Programmer. He is the editor of SocialNews.XYZ and President of AGK Fire Inc.

 

He enjoys designing websites, developing mobile applications and publishing news articles on current events from various authenticated news sources.

When it comes to writing he likes to write about current world politics and Indian Movies. His future plans include developing SocialNews.XYZ into a News website that has no bias or judgment towards any.

He can be reached at gopi@socialnews.xyz

Summary
Title
FDA approves drug to treat postpartum depression (Video)
Description

The U.S. Food and Drug Administration has approved the first drug specifically developed to treat postpartum depression. The agency on Tuesday approved Sage Therapeutics' Zulresso, a physician administered IV drug given over 2 ½ days. (March 20) Subscribe for more Breaking News: http://smarturl.it/AssociatedPress Website: https://apnews.com Twitter: https://twitter.com/AP Facebook: https://facebook.com/APNews Google+: https://plus.google.com/115892241801867723374 Instagram: https://www.instagram.com/APNews/ ​ You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/84d2a6abe6681a534e12d41b878068f7

%d bloggers like this: